Evaluation of treatment and management effect of DOTS combined with WeChat on pulmonary tuberculosis patients

doi:10.3969/j.issn.2096-8493.2021.01.011

Abstract

Abstract:

Objective To evaluate the application effect of directly observed treatment short curse (DOTS) combined with WeChat in the treatment and management of tuberculosis patients. Methods From January 1, 2018 to December 31, 2019, a total of 1988 registered active pulmonary tuberculosis patients meeting the inclusion criteria in Zibo were enrolled. According to the principle of informed consent, they were dived into DOTS+WeChat group (n=836) and single DOTS group (n=1152) cases were treated with management. The regular medication, treatment and outcome (the coincidence rate of sputum test times, the sputum negative conversion rates at the end of 2 months, the success rate of treatment), and patient management (the rate of supervision management and follow-up management) of the two groups were compared. Results The regular medication rate of single DOTS was statistically lower than that of DOTS+WeChat group (92.10% (1061/1152) vs. 98.80% (826/836); χ²=45.138, P<0.001). In terms of treatment and outcome, there was no significant difference between the two groups, the sputum negative conversion rates at the end of 2 months were 95.82% (436/455) in the single DOTS group and 97.44% (343/352) in the DOTS+WeChat group (χ²=1.553, P=0.213). The coincidence rate of sputum test times and the success rate of treatment in the DOTS+WeChat group were both significantly higher than those in the single DOTS group (95.81% (801/836) vs. 90.19% (1039/1152), χ²=22.230, P<0.001; 98.68% (825/836) vs. 96.53% (1112/1152), χ²=9.013, P=0.003). As to the supervision and follow-up management, the rates of supervision and follow-up management were both 100.00% in the two groups; while the rate of medical staff participating in supervision and management in the DOTS+WeChat group was significantly higher than that in the single DOTS group (100.00% (836/836) vs. 75.87% (874/1152), χ²=17.330, P<0.001). The complete follow-up rate in consolidation period and the rate of follow-up during the whole course in the single DOTS+WeChat group were significantly lower than those in the DOTS+WeChat group (98.35% (1133/1152) vs. 100.00% (836/836), χ²=13.921, P<0.001; 98.09% (1130/1152) vs. 99.76% (834/836), χ²=11.335, P=0.001). Conclusion The treatment management of DOTS combined with WeChat was better than the single DOTS, it was a feasible and effective management for tuberculosis patient.

Key words: Tuberculosis, pulmonary, Care management, WeChat, Outcome and process assessment (health care)

LI Yuan, GAO Feng-hua, JIN Feng. Evaluation of treatment and management effect of DOTS combined with WeChat on pulmonary tuberculosis patients[J]. Journal of Tuberculosis and Lung Disease , 2021, 2(1): 50-53. doi: 10.3969/j.issn.2096-8493.2021.01.011

Figures/Tables 1

临床特征	DOTS组(1152例)	DOTS+微信组(836例)	检验值	P值
性别			χ²=0.511	0.475
男	766(66.49)	543(64.95)
女	386(33.51)	293(35.05)
年龄(岁, $x ˉ$ ±s)	45.0±1.3	47.0±2.1	t=0.881	0.318
文化程度			χ²=0.726	0.696
小学及以下	31(2.69)	22(2.63)
初/高中	1039(90.19)	747(89.36)
本科及以上	82(7.12)	67(8.01)
病原学检查结果			χ²=1.367	0.242
阳性	455(39.50)	352(42.11)
阴性	697(60.50)	484(57.89)
患者类型			χ²=0.106	0.745
初治	1140(98.96)	826(98.80)
复治	12(1.04)	10(1.20)

References 9

[1]	中华人民共和国卫生部疾病预防控制局, 中华人民共和国卫生部医政司, 中国疾病预防控制中心. 中国结核病防治规划实施工作指南(2008年版).北京: 中国协和医科大学出版社, 2009: 54.
[2]	孙大娟. 不同电话督导与传统督导方式对肺结核患者治疗管理效果的探讨. 心理医生, 2018,24(18):91-92.
[3]	赖培烜, 秦道新, 田园, 等. 互联网技术+手机微信小程序的患者管理模式探讨. 中国热带医学, 2020,20(4):394-396. doi: 10.13604/j.cnki.46-1064/r.2020.04.22.
[4]	房宏霞, 谢艳光, 秦玉宝, 等. 手机在结核病患者治疗管理中的应用. 中国防痨杂志, 2015,37(9):966-970. doi: 10.3969/j.issn.1000-6621.2015.05.010. doi: doi:10.3969/j.issn.1000-6621.2015.05.010 URL
[5]	李亚敏, 高志东, 陈曦, 等. 移动互联网技术用于社区肺结核患者健康管理的接受意愿调查分析. 中国防痨杂志, 2020,42(12):1313-1317. doi: 10.3969/j.issn.1000-6621.2020.12.012.
[6]	刘盛元, 谭卫国, 杨亚蕊, 等. 重视信息化技术应用促进结核病防治工作. 结核病与肺部健康杂志, 2018,7(1):3-8. doi: 10.3969/j.issn.2095-3755.2018.01.002.
[7]	刘萍萍, 林伟斌, 钟耐容, 等. 基于互联网微信平台的流动人口肺结核患者健康教育研究. 中国防痨杂志, 2017,39(7):713-716. doi: 10.3969/j.issn.1000-6621.2017.07.009.
[8]	吴洁, 赵明伟, 宁峰, 等. 微信公众平台对高校学生志愿者结核病健康教育的效果评价. 中国防痨杂志, 2016,38(7):588-591. doi: 10.3969/j.issn.1000-6621.2016.07.015.
[9]	景睿, 曹艳民, 杨一军, 等. 电子药盒和手机微信APP对肺结核患者督导服药管理的应用研究. 结核与肺部疾病杂志, 2020,1(1):96-99. doi: 10.3969/j.issn.2096-8493.2020.01.020.

[1]	ZHANG Zhi-guo, GUO Hai-ping, PANG Yu. Considerations for the application of laboratory diagnostics in detecting drug-resistant tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2021, 2(1): 13-17.
[2]	WANG Zhi-hui, DONG Ya-kun, CHI Yue-peng, DI Hong-qin, LIANG Ya-chong, XIE Lan-pin. Evaluation of the application value of fluorescence PCR probe melting curve method in detecting drug resistance in elderly pulmonary tuberculosis patients [J]. Journal of Tuberculosis and Lung Disease, 2021, 2(1): 18-22.
[3]	WANG Lian-bo, ZHANG Zhi-hua, LIU Feng-sheng, JIA Chen-guang, DONG Zhao-liang, YAO Xiao-wei, WU Shu-cai. Application value of GeneXpert MTB/RIF in diagnosis of joint tuberculosis and detection of rifampin resistance [J]. Journal of Tuberculosis and Lung Disease, 2021, 2(1): 23-25.
[4]	ZHANG Zhe-nan, JIANG Nan-yang, WANG Wei, JIANG Lian-ju, LIU Yu-qin. Analysis of the effectiveness of two different surgical methods on treating cervical lymph node tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2021, 2(1): 26-30.
[5]	XIAO Juan, PI Hong-lin, SUN Qing-peng. Analysis of clinical characteristics and therapeutic effect of 96 patients with spinal tuberculosis underwent surgical treatment [J]. Journal of Tuberculosis and Lung Disease, 2021, 2(1): 38-42.
[6]	FANG Lan-jun, WU Hui-zhong, HUANG Shan-shan, WEN Wen-pei, ZHOU Lin, CHEN Liang. Evaluation of intervention effect of WeChat health education on the knowledge, belief, and behavior of tuberculosis prevention and treatment in college freshmen [J]. Journal of Tuberculosis and Lung Disease, 2021, 2(1): 54-57.
[7]	SUN Ming-lei, GUAN Li, LIANG Li-bo, ZHAO Juan, WANG Chen, ZOU Dan-dan. Bibliometric analysis of tuberculosis patient and care system delay based on Web of Science core database [J]. Journal of Tuberculosis and Lung Disease, 2021, 2(1): 62-68.
[8]	JIAO Wei-wei. Advances in molecular diagnostic techniques of tuberculosis in children [J]. Journal of Tuberculosis and Lung Disease, 2021, 2(1): 69-72.
[9]	GUI Xu-wei, KE Hui, GU Jin. Progress of diagnostic research in biomarkers tuberculous pleurisy [J]. Journal of Tuberculosis and Lung Disease, 2021, 2(1): 73-77.
[10]	GUI Min, CHEN Jing-fang, DENG Guo-fang, FU Liang, ZENG Gu-qing. Research progress on the effectiveness and adverse reactions of clofazimine in the treatment of multidrug-resistant tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2021, 2(1): 78-82.
[11]	HAN Li-jun, ZHAO Xue-yao. Molecular detection technologies for diagnosing tuberculous meningitis using cerebrospinal fluid [J]. Journal of Tuberculosis and Lung Disease, 2021, 2(1): 8-12.
[12]	HAN Mei, HAN Pu, CHEN Ya-ting, YANG Song, YAN Xiao-feng. Study progress on the application of sputum induction in the etiological diagnosis of pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2021, 2(1): 83-87.
[13]	ZHU Guo-feng, LIU Xiao-qing. The new era of systematic immunology of tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(3): 195-212.
[14]	YI Jun-li, YANG Xin-yu, ZHANG Jie, TIAN Li-li, DING Bei-chuan, WU Wen-qing. Application evaluation of three methods for identification between Mycobacterium tuberculosis complex and non-tuberculous mycobacteria [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(3): 240-244.
[15]	SU Bi-yi, ZHOU De-wang, MA Pin-yun, GUAN Ping, TAN Yao-ju. Diagnostic value of melting curve method in detecting resistance of Mycobacterium tuberculosis to rifampicin and isoniazid [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(3): 245-248.